Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
134.21
-1.12 (-0.83%)
At close: Jul 11, 2025, 4:00 PM
135.00
+0.79 (0.59%)
After-hours: Jul 11, 2025, 7:35 PM EDT
Biogen Stock Forecast
Stock Price Forecast
The 27 analysts that cover Biogen stock have a consensus rating of "Buy" and an average price target of $188.17, which forecasts a 40.21% increase in the stock price over the next year. The lowest target is $115 and the highest is $292.
Price Target: $188.17 (+40.21%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 | 5 | 5 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 14 | 14 | 15 | 15 | 16 | 16 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 27 | 28 | 27 | 27 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $213 | Buy | Reiterates | $213 | +58.71% | Jun 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $187 | Strong Buy | Reiterates | $187 | +39.33% | Jun 26, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $205 → $213 | Buy | Maintains | $205 → $213 | +58.71% | Jun 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $115 | Hold | Reiterates | $115 | -14.31% | Jun 12, 2025 |
| Wedbush | Wedbush | Hold Reiterates $121 | Hold | Reiterates | $121 | -9.84% | Jun 12, 2025 |
Financial Forecast
Revenue This Year
9.45B
from 9.68B
Decreased by -2.32%
Revenue Next Year
9.27B
from 9.45B
Decreased by -1.87%
EPS This Year
15.27
from 11.18
Increased by 36.56%
EPS Next Year
15.74
from 15.27
Increased by 3.12%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.1B | 10.1B | 10.4B | ||
| Avg | 9.5B | 9.3B | 9.4B | ||
| Low | 8.8B | 8.2B | 8.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.2% | 6.7% | 12.1% | ||
| Avg | -2.3% | -1.9% | 1.3% | ||
| Low | -8.8% | -13.2% | -11.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.70 | 18.82 | 20.61 | ||
| Avg | 15.27 | 15.74 | 16.63 | ||
| Low | 14.04 | 12.48 | 12.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 49.3% | 23.2% | 30.9% | ||
| Avg | 36.6% | 3.1% | 5.6% | ||
| Low | 25.6% | -18.3% | -19.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.